Infective endocarditis developing early after percutaneous closure of a patent ductus arteriosus in a child using the Amplatzer Duct Occluder II.
Murat Muhtar YilmazerTimur MeşePublished in: Cardiology in the young (2020)
A 10-month-old girl underwent patent ductus arteriosus closure with an Amplatzer Duct Occluder II. After 1 week, she was admitted to our emergency room with tachypnoea, fatigue, and fever. Consecutive blood cultures yielded vancomycin-sensitive Staphylococcus aureus. The patient was already receiving vancomycin, but the fever did not respond to this treatment. The device was successfully removed via left lateral thoracotomy.
Keyphrases
- staphylococcus aureus
- methicillin resistant staphylococcus aureus
- left atrial appendage
- minimally invasive
- public health
- emergency department
- mental health
- healthcare
- case report
- biofilm formation
- clinical trial
- heart failure
- escherichia coli
- atrial fibrillation
- sleep quality
- pseudomonas aeruginosa
- physical activity
- combination therapy
- placebo controlled
- aortic valve
- emergency medical
- candida albicans
- double blind